| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 739.24 KB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
Ao longo dos Ășltimos anos, a Quarta Revolução Industrial tem vindo a ganhar forma. VĂĄrios
paĂses tencionam implementar os conceitos da IndĂșstria 4.0 e desenvolveram jĂĄ estratĂ©gias para
o realizar num futuro próximo. Esta revolução caracteriza-se pelo desenvolvimento de sistemas
totalmente interligados e colaborativos, utilizando tecnologias emergentes, como a Big Data,
Internet of Things, Cyber-Physical Systems, Digital Twins e InteligĂȘncia Artificial.
A implementação destas tecnologias inovadoras na indĂșstria farmacĂȘutica, que tomou o nome
Pharma 4.0, promete revolucionar o mercado farmacĂȘutico, as cadeias de distribuição e a
qualidade dos produtos farmacĂȘuticos. No futuro, serĂĄ possĂvel adotar processos de produção
contĂnua e produzir fĂĄrmacos e outros produtos de saĂșde de forma mais eficiente, transparente
e lucrativa, com recurso a sistemas de controlo avançado dos processos com caracterĂsticas
auto-adaptativas, preditivas e proativas.
Implementar este modelo operacional Pharma 4.0 pode, no entanto, ser muito desafiante para
as empresas do setor farmacĂȘutico. TerĂŁo de ser reunidas condiçÔes favorĂĄveis Ă inovação e,
posteriormente, fazer este percurso de forma gradual e consistente. A jornada Ă© longa, mas os
benefĂcios parecem superar os riscos. A produção de medicina personalizada, a flexibilidade
dos processos de produção, a tomada de decisĂ”es mais informada e o controlo holĂstico do ciclo
de vida dos produtos farmacĂȘuticos sĂŁo algumas das possibilidades com o desenvolvimento na
direção da Pharma 4.0.
As entidades reguladoras jĂĄ se mostraram favorĂĄveis ao progresso e parecem incentivar a
modernização da indĂșstria farmacĂȘutica, produzindo guidelines que estabelecem as bases para
a implementação de estratĂ©gias de gestĂŁo para a indĂșstria farmacĂȘutica, rumo Ă Pharma 4.0.
Over the last few years, the Fourth Industrial Revolution has been taking shape. Several countries plan on implementing Industry 4.0âs concepts and have already designed strategies to achieve it in the near future. This revolution is characterized by the development of totally integrated and collaborative systems, using emerging technologies such as Big Data, Internet of Things, Cyber-Physical Systems, Digital Twins and Artificial Intelligence. The application of these new technologies in the pharmaceutical industry has been named Pharma 4.0, and promises to revolutionize the pharma market, its supply chains, and the product quality. In the future, it will be possible to adopt continuous production processes and to produce in a more efficient, transparent, and lucrative way. This can be achieved using process advanced control systems with auto-adaptative, predictive and proactive characteristics. Implementing Pharma 4.0 operating model can be very challenging to corporations. Suitable conditions for innovation will need to be established to take this path. The journey is long, but the benefits seem to outweigh the risks. The production of personalized medicine, the flexibility of the production processes, the ability to make more informed decisions, and a holistic control of the product life cycle are some of the possibilities that come with the development towards Pharma 4.0. Regulatory bodies are in favour of this progress and seem to be inciting pharmaceutical industryâs modernization by coming with guidelines that lay the groundwork to help initiate management strategies for pharma industry to better cope with the task of putting Pharma 4.0 to practice.
Over the last few years, the Fourth Industrial Revolution has been taking shape. Several countries plan on implementing Industry 4.0âs concepts and have already designed strategies to achieve it in the near future. This revolution is characterized by the development of totally integrated and collaborative systems, using emerging technologies such as Big Data, Internet of Things, Cyber-Physical Systems, Digital Twins and Artificial Intelligence. The application of these new technologies in the pharmaceutical industry has been named Pharma 4.0, and promises to revolutionize the pharma market, its supply chains, and the product quality. In the future, it will be possible to adopt continuous production processes and to produce in a more efficient, transparent, and lucrative way. This can be achieved using process advanced control systems with auto-adaptative, predictive and proactive characteristics. Implementing Pharma 4.0 operating model can be very challenging to corporations. Suitable conditions for innovation will need to be established to take this path. The journey is long, but the benefits seem to outweigh the risks. The production of personalized medicine, the flexibility of the production processes, the ability to make more informed decisions, and a holistic control of the product life cycle are some of the possibilities that come with the development towards Pharma 4.0. Regulatory bodies are in favour of this progress and seem to be inciting pharmaceutical industryâs modernization by coming with guidelines that lay the groundwork to help initiate management strategies for pharma industry to better cope with the task of putting Pharma 4.0 to practice.
Description
Trabalho Final de Mestrado Integrado, CiĂȘncias FarmacĂȘuticas, 2021, Universidade de Lisboa, Faculdade de FarmĂĄcia.
Keywords
IndĂșstria 4.0 IndĂșstria FarmacĂȘutica 4.0 Pharma 4.0 Modelo operacional pharma 4.0 Produção Mestrado integrado - 2021